Altamira Therapeutics Ltd. Gains 180.22%
Wed, Nov 29, 2023 at 07:45 PM
Altamira Therapeutics Ltd. (CYTO:NASDAQ) soared at $0.64, a gain of 180.2%. On Wed, Nov 29, 2023, CYTO:NASDAQ touched a New 2-Week High of $0.64. The stock got featured on our News Catalysts scanner on Wed, Nov 29, 2023 at 01:19 PM in the 'MISCELLANEOUS' category. From Thu, Nov 16, 2023, the stock recorded 62.50% Up Days and 55.56% Green Days
About Altamira Therapeutics Ltd. (CYTO:NASDAQ)
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.
Top 10 Gainers:
- Vivos Therapeutics Inc. (VVOS:NASDAQ), 831.82%
- Unico American Corporation (UNAM:NASDAQ), 354.55%
- Altamira Therapeutics Ltd. (CYTO:NASDAQ), 180.22%
- PROOF Acquisition Corp I Class A (PACI:NYSE), 148.32%
- Yoshiharu Global Co. (YOSH:NASDAQ), 93.11%
- Conduit Pharmaceuticals Inc Com (CDT:NASDAQ), 72.88%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 65.19%
- Envoy Med Inc Cl A (COCH:NASDAQ), 55.93%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 55.87%
- Statera Biopharma Inc. (STAB:NASDAQ), 50%